Study Group: Biostatisticians (US)(?)
Council Members in this Study Group: 270
Request a survey with this Study Group
Leading Experts in this Study Group
Transfusion Service Director
Hennepin County Medical Center
Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...
Founder and President
BioRankings, LLC
William Shannon, PhD, is a tenured Associate Professor of Biostatistics and the Director of Biostatistical Consulting Center in Department of Medicine at Washington University School of Medicine. He is responsible for research and development of new statistical methods for molecular data analysis, and...
Professor
UNIVERSITY OF ALABAMA AT BIRMINGHAM
Alfred Bartolucci, PhD, is a Professor of Biostatistics at University of Alabama at Birmingham. Dr. Bartolucci’s areas of expertise in applied statistics are oncology , Alzheimer's disease, cardiovascular disease, statistical genetic association research, and Systemic Lupus Erythematosus. His areas...
Chief, Division of Nephrology
Stanford University School of Medicine
Glenn Chertow, MD, MPH, is Professor of Medicine and Chief, Division of Nephrology, at Stanford University School of Medicine and Director of Nephrology Services at Stanford Hospital and Clinics. His research interests are focused on epidemiology, health services research, and clinical trials in acute...
Charles Glueck, MDMedical Research Director of Cholesterol Center
Jewish Hospital
Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Biostatisticians | 401 |
| Oncologists (US) | 2247 |
| Emergency Medicine Physicians (US) | 1099 |
| General Cardiologists (US) | 1333 |
| Critical Care Physicians (US) | 344 |
| Critical Care Physicians | 732 |
| Pathologists (US) | 812 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
An August 2008 study analyzing the National Ambulatory Medical Care Survey (NAMCA) database shows a significant decrease in the amount of psychotherapy that psychiatrists are providing for their patients, while at the same time possibly showing an increase in medications prescribed. This correlation...
Slowing the progression of Alzheimer's disease by attacking tau tangles is a novel idea that should be considered a viable treatment alternative, especially in light of the failings of some recent beta-amyloid treatment strategies (e.g., Flurizan). At the 2008 International Conference on...
The authors of this NEJM Special Report define subgroup analysis as “any evaluation of treatment effects for a specific end point in subgroups of patients defined by baseline characteristics.” When done appropriately, subgroup analysis are valuable. However, when done post hoc they can lead to incorrect...
Market impact is huge for many reasons. First, carvedilol is postulated to be a more effective beta blocker in the management of CHF with reduced ejection fraction compared to other generics and name brand ones on the market. This is based on a number of clinical trials demonstrating superiority in...
Because bone void fillers are approved as devices, not drugs, they do not need to demonstrate efficacy, just safety. Orthopaedic surgeons are looking past bone void fillers to products that are more biologically active.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Professor
- Research Scientist
- Director
- Assistant Professor
- Researcher
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

